Clinical Trials Browser

OTHER_GOV × nimotuzumab × Clear all

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms